tert-Butyldiphenylsilyl trifluoromethanesulfonate, 95.0%, 1g

8-Bromo-quinoline, 97.00%, 5g

4'-cyano-2-pyrrolidinomethyl benzophenone, 97.0%, 1g

PMPip BTA, 25 g, >=99%, glass packaging

4,6-Dichloro-2-(3,4-dichlorophenyl)pyrimidine, 98%, 500mg

Extraction system BioChemVacuuCenter BVC Model Control, BVC Control G, 2 l glass collection bottle, with hose connections, 1 piece

2,2-Diphenylacetohydrazide, 95.0%, 5g

(1,3-Dimethyl-1H-indazol-5-yl)boronic acid, 95.0%, 1g

2-Dodecyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

tert-Butyl 1H-pyrazole-4-carboxylate, 97.0%, 100g

(4-Bromo-3-iodophenyl)methanol, 95+%, 250mg

1-Methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid, 95.0%, 50g

[(5-ethyl-4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetic acid, 95.0%, 500mg